Solomon M J, Lee T, Kirschner M W
Department of Biochemistry and Biophysics, University of California, San Francisco 94143-0448.
Mol Biol Cell. 1992 Jan;3(1):13-27. doi: 10.1091/mbc.3.1.13.
Phosphorylation of p34cdc2 can both positively and negatively regulate its kinase activity. We have mapped two phosphorylation sites in Xenopus p34cdc2 to Thr-14 and Tyr-15 within the putative ATP-binding region of p34cdc2. Mutation of these sites to Ala-14 and Phe-15 has no effect on the final histone H1 kinase activity of the cyclin/p34cdc2 complex. Phosphopeptide analysis shows that there is at least one more site of phosphorylation on p34cdc2. When Thr-161 is changed to Ala, two phosphopeptide spots disappear and it is no longer possible to activate the H1 kinase activity of p34cdc2. We suggest that Thr-161 is a third site of phosphorylation, which is required for kinase activity. All three phosphorylations are induced by cyclin. None of the phosphorylations appears to be required for binding to cyclin, as indicated by the ability of the triple mutant, Ala-14, Phe-15, Ala-161, to bind cyclin. The activating phosphorylation that requires Thr- or Ser-161 occurs even in a catalytically inactive K33R mutant of p34cdc2 and hence does not appear to be the result of intramolecular autophosphorylation. We have detected an activity in Xenopus extracts required for activation of p34cdc2 and present evidence that this is a p34cdc2 activating kinase which, in a cyclin-dependent manner, probably directly phosphorylates Thr-161.
p34cdc2的磷酸化既能正向调节也能负向调节其激酶活性。我们已将非洲爪蟾p34cdc2中的两个磷酸化位点定位到p34cdc2假定的ATP结合区域内的苏氨酸-14和酪氨酸-15。将这些位点突变为丙氨酸-14和苯丙氨酸-15对细胞周期蛋白/p34cdc2复合物的最终组蛋白H1激酶活性没有影响。磷酸肽分析表明,p34cdc2上至少还有一个磷酸化位点。当苏氨酸-161变为丙氨酸时,两个磷酸肽斑点消失,并且不再能够激活p34cdc2的H1激酶活性。我们认为苏氨酸-161是第三个磷酸化位点,它是激酶活性所必需的。所有这三种磷酸化都是由细胞周期蛋白诱导的。如三突变体丙氨酸-14、苯丙氨酸-15、丙氨酸-161与细胞周期蛋白结合的能力所示,似乎没有一种磷酸化是与细胞周期蛋白结合所必需的。即使在催化无活性的p34cdc2的K33R突变体中,需要苏氨酸或丝氨酸-161的激活磷酸化也会发生,因此似乎不是分子内自磷酸化的结果。我们在非洲爪蟾提取物中检测到一种激活p34cdc2所需的活性,并提供证据表明这是一种p34cdc2激活激酶,它以细胞周期蛋白依赖性方式可能直接磷酸化苏氨酸-161。